N/A
Completed N=60
Study to Evaluate Satisfaction After Treatment With Restylane
Cheek Augmentation
Source: ClinicalTrials.gov NCT04638816 ↗
Enrolled (actual)
60
Serious AEs
0.0%
Results posted
Mar 2024
Primary outcomePrimary: Assess Treatment With Restylane Volyme and Restylane Lyft Lidocaine Using GAIS — 20; 17; 9; 9 Participants
Summary
Open-label, phase IV, post-marketing study to evaluate aesthetic improvement and satisfaction after treatment with Restylane
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Assess Treatment With Restylane Volyme and Restylane Lyft Lidocaine Using GAIS |
20; 17; 9; 9; 1; 3 | — |
Eligibility Criteria
Inclusion Criteria
- Signed and dated informed consent to participate in the study
- Adult women who intend to undergo cheek augmentation
Exclusion Criteria
- Subjects presenting with known allergy to HA (hyaluronic acid) filler or amide local anesthetics
- Subjects with a previous implant other than HA in or near the intended treatment site
- Participation in any other clinical study within three (3) months before treatment
Data sourced from ClinicalTrials.gov (NCT04638816). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.